Co-Founder & CEO
IL
Isomorphic Labs
Shutdownisomorphic.cloud
Website unreachable since Oct 31, 2026
The startup employs an AI-first methodology to fundamentally transform the drug discovery process, utilizing machine learning algorithms to predict molecular interactions and optimize compound selection. This approach addresses the inefficiencies and high costs associated with traditional drug development, significantly accelerating the timeline from research to market.
- Artificial Intelligence
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$600MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup employs an AI-first methodology to fundamentally transform the drug discovery process, utilizing machine learning algorithms to predict molecular interactions and optimize compound selection. This approach addresses the inefficiencies and high costs associated with traditional drug development, significantly accelerating the timeline from research to market.